Mergenet Solutions Inc, a medical technology business incubator located in Deerfield Beach, Fla, will extend its shareholder dividend claim deadline. Mergenet Solutions currently incubates such companies as Innomed Healthscience Inc, whose product in development is expected to address obstructive sleep apnea (OSA), COPD, and other modalities; and Mergenet Medical Inc, whose product in development includes high flow oxygen therapy with pressure monitoring.
The deadline has been extended through June 15, 2018. Forms may be obtained from the company or company’s stock transfer agent.
